Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

VA study reveals hurdles transgender veterans face in getting Gender-Affirming care

NCT ID NCT06615401

First seen Nov 03, 2025

Summary

This completed study surveyed 986 transgender Veterans to learn what helps or hinders them from getting gender-affirming treatments like hormone therapy and mental health care through the VA or community providers. The goal is to identify barriers and facilitators so the VA can improve access and support. No new treatments were tested; instead, the study gathers insights to guide future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENDER DYSPHORIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • VA Bedford HealthCare System, Bedford, MA

    Bedford, Massachusetts, 01730-1114, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could help the VA improve access to gender-affirming treatments for transgender Veterans, potentially reducing mental health risks and suicide.

What could go wrong

This is an observational survey study, not a treatment trial. It identifies barriers but does not test any intervention, so it cannot directly improve care.

Conditions

The condition(s) this trial relates to.

Gender Dysphoria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.